These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

864 related items for PubMed ID: 27932154

  • 1. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A, Piecha G, Więcek A.
    Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
    [Abstract] [Full Text] [Related]

  • 2. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 3. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A, Kaori S, Takei T, Nitta K.
    CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY.
    Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
    [Abstract] [Full Text] [Related]

  • 5. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 Jan; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 6. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E.
    Am J Nephrol; 2017 Jan; 46(2):108-113. PubMed ID: 28700988
    [Abstract] [Full Text] [Related]

  • 7. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis.
    Meyer TN, Thaiss F, Stahl RA.
    Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957
    [Abstract] [Full Text] [Related]

  • 8. Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation.
    Gonzalez E, Ettenger R, Rianthavorn P, Tsai E, Malekzadeh M.
    Pediatr Transplant; 2011 Aug; 15(5):495-501. PubMed ID: 21338460
    [Abstract] [Full Text] [Related]

  • 9. Successful Reuse of Kidney Graft After Early Recurrence of Primary Focal and Segmental Glomerulosclerosis.
    Hamroun A, Gibier JB, Maanaoui M, Lionet A, Gnemmi V, Bouyé S, Fantoni JC, Averland B, Antoine C, Lenain R, Hazzan M, Provôt F.
    Am J Kidney Dis; 2021 Dec; 78(6):897-901. PubMed ID: 34118304
    [Abstract] [Full Text] [Related]

  • 10. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification.
    Unagami K, Kawanishi K, Shimizu T, Kanzawa T, Toki D, Okumi M, Omoto K, Horita S, Koike J, Honda K, Nagashima Y, Ishida H, Tanabe K, Nitta K.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():96-100. PubMed ID: 26031598
    [Abstract] [Full Text] [Related]

  • 11. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M.
    Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
    [Abstract] [Full Text] [Related]

  • 12. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.
    Argiolas D, Carta E, Mascia G, Michittu MB, Piredda GB.
    Transplant Proc; 2019 Mar; 51(1):223-225. PubMed ID: 30580884
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation.
    Mitome J, Yamamoto H, Maruyama Y, Kobayashi A, Yaginuma T, Matsuo N, Tanno Y, Hayakawa H, Miyazaki Y, Yokoyama K, Utsunomiya Y, Yamaguchi Y, Hosoya T.
    Clin Transplant; 2010 Jul; 24 Suppl 22():48-53. PubMed ID: 20590695
    [Abstract] [Full Text] [Related]

  • 14. Recurrence of focal segmental glomerulosclerosis after renal transplantation: a case report.
    Akash N.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):91-4. PubMed ID: 17237899
    [Abstract] [Full Text] [Related]

  • 15. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F, Simková E, Vondrák K, Janda J, Chadimová M, Stejskal J, Seeman T.
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [Abstract] [Full Text] [Related]

  • 16. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child.
    Solomon S, Zolotnitskaya A, Del Rio M.
    Pediatr Transplant; 2019 Jun; 23(4):e13413. PubMed ID: 30973669
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH, Lee JH, Park GY, Lim JH, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.
    Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
    [Abstract] [Full Text] [Related]

  • 18. Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.
    Colucci M, Labbadia R, Vivarelli M, Camassei FD, Emma F, Dello Strologo L.
    Pediatr Nephrol; 2020 Feb; 35(2):341-345. PubMed ID: 31667616
    [Abstract] [Full Text] [Related]

  • 19. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports.
    Kamar N, Faguer S, Esposito L, Guitard J, Nogier MB, Durand D, Rostaing L.
    Clin Nephrol; 2007 Apr; 67(4):250-4. PubMed ID: 17474562
    [Abstract] [Full Text] [Related]

  • 20. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    McCarthy ET, Sharma M, Savin VJ.
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.